Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
IONS: Ionis Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
IONS
The Story
IONS
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-10.5% / yr
Operating margin
-68.1%
ROIC
-20.4%
Financially safe
Stretched
Debt / equity
5.50×
Interest coverage
-8.3×
Current ratio
7.88×
Ionis Pharmaceuticals, Inc.
IONS
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Ionis Pharmaceuticals, Inc.
IONS
NASDAQ
·
USD
·
Closed
$51.77
−2.83%
$51.77
−$1.51 (2.83%)
52W Range
25th
pctl
Volume
0.91×
avg
Mkt Cap
8.60B
USD
P/E
-15.0
TTM
Div Yield
–
ann
52W Range
25th
pctl
Volume
0.91×
avg
Market Cap
8.60B
USD
P/E Ratio
-15.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings